Beranda › Kanker Paru Non-Sel Kecil › North Carolina › Charlotte
Uji klinis Kanker Paru Non-Sel Kecil di Charlotte, NC
19 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Charlotte (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Menerima pesertaFase 3
- Novant Health Weisiger Cancer Insititute ( Site 0266), Charlotte
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Menerima pesertaFase 3
- Carolinas Medical Center, Charlotte
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
Menerima pesertaFase 2
- Levine Cancer Institute, Charlotte
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Atrium Health, Charlotte
Pan-tumor MRD Study
Menerima pesertaStudi observasional
- Carolina Oncology Specialists, Charlotte
Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
Menerima pesertaFase 2
- Atrium Health Levine Cancer, Charlotte
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Menerima pesertaFase 1/2
- Carolina Biooncology Institute, Huntersville · 13 mi jauhnya
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Menerima pesertaFase 3
- Levine Cancer Institute, Charlotte
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Menerima pesertaFase 1/2
- Carolina BioOncology Institute, LLC, Huntersville · 13 mi jauhnya
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Menerima pesertaFase 1/2
- Levine Cancer Institute - Charlotte, Charlotte
Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study
Menerima pesertaStudi observasional
- Atrium Health Levine Cancer, Charlotte
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Clinical Trial Site, Huntersville · 13 mi jauhnya
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Menerima pesertaFase 1
- Carolina BioOncology Institute /ID# 232597, Huntersville · 13 mi jauhnya
Study of XB010 in Subjects With Solid Tumors
Menerima pesertaFase 1
- Carolina BioOncology Institute, Huntersville · 13 mi jauhnya
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Menerima pesertaFase 1
- Carolina BioOncology Institute, Huntersville · 13 mi jauhnya
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Menerima pesertaFase 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi jauhnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Levine Cancer Institute-SouthPark, Charlotte
- dan 8 lainnya
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi jauhnya
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Menerima pesertaFase 1
- Dren Investigational Site, Huntersville · 13 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Charlotte
- Kanker (semua jenis)27 studi
- Kanker Payudara22 studi
- Mieloma Multipel21 studi
- Leukemia Mieloid Akut16 studi
- Obesitas16 studi
- Kelebihan Berat Badan15 studi
- Kanker Kolorektal13 studi
- Kanker Ovarium12 studi
- Gagal Jantung11 studi
- Kanker Metastatik11 studi
- Karsinoma Sel Skuamosa Kepala dan Leher10 studi
- PPOK9 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.